{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T12:12:59Z","timestamp":1775736779522,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T00:00:00Z","timestamp":1730937600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head and Neck Pathol"],"DOI":"10.1007\/s12105-024-01694-7","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T09:31:25Z","timestamp":1730971885000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeted RNA Sequencing of Head and Neck Adenoid Cystic Carcinoma Reveals SEC16A::NOTCH1 Fusion and MET Exon 14 Skipping as Potentially Actionable Alterations"],"prefix":"10.1007","volume":"18","author":[{"given":"Ying-Hsia","family":"Chu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Purvil","family":"Sukhadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinita S.","family":"Mohanty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara E.","family":"DiNapoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan L.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Katabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Snjezana","family":"Dogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"1694_CR1","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s12105-022-01459-0","volume":"16","author":"I Alsanie","year":"2022","unstructured":"Alsanie I, Rajab S, Cottom H et al (2022) Distribution and frequency of salivary gland tumours: an International Multicenter Study. Head Neck Pathol 16:1043\u20131054","journal-title":"Head Neck Pathol"},{"key":"1694_CR2","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S0002-9610(97)00153-0","volume":"174","author":"RH Spiro","year":"1997","unstructured":"Spiro RH (1997) Distant metastasis in adenoid cystic carcinoma of salivary origin. Am J Surg 174:495\u2013498","journal-title":"Am J Surg"},{"key":"1694_CR3","first-page":"3045","volume":"37","author":"S Jang","year":"2017","unstructured":"Jang S, Patel PN, Kimple RJ, McCulloch TM (2017) Clinical outcomes and prognostic factors of adenoid cystic carcinoma of the Head and Neck. Anticancer Res 37:3045\u20133052","journal-title":"Anticancer Res"},{"key":"1694_CR4","doi-asserted-by":"publisher","first-page":"100274","DOI":"10.1016\/j.modpat.2023.100274","volume":"36","author":"K Ueda","year":"2023","unstructured":"Ueda K, Murase T, Kawakita D et al (2023) The Landscape of MYB\/MYBL1- and Peri-MYB\/MYBL1-Associated rearrangements in adenoid cystic carcinoma. Mod Pathol 36:100274","journal-title":"Mod Pathol"},{"key":"1694_CR5","doi-asserted-by":"crossref","unstructured":"Miller LE, Au V, Mokhtari TE et al (2022) A contemporary review of molecular therapeutic targets for adenoid cystic carcinoma. Cancers (Basel);14:992","DOI":"10.3390\/cancers14040992"},{"key":"1694_CR6","doi-asserted-by":"publisher","first-page":"4712","DOI":"10.1158\/1078-0432.CCR-19-0225","volume":"25","author":"R Benayed","year":"2019","unstructured":"Benayed R, Offin M, Mullaney K et al (2019) High yield of RNA sequencing for targetable kinase fusions in lung adenocarcinomas with no mitogenic driver alteration detected by DNA sequencing and low Tumor Mutation Burden. Clin Cancer Res 25:4712\u20134722","journal-title":"Clin Cancer Res"},{"key":"1694_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/ng.3466","volume":"48","author":"X Zhou","year":"2016","unstructured":"Zhou X, Edmonson MN, Wilkinson MR et al (2016) Exploring genomic alteration in pediatric cancer using ProteinPaint. Nat Genet 48:4\u20136","journal-title":"Nat Genet"},{"key":"1694_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng DT, Mitchell TN, Zehir A et al (2015) Memorial Sloan Kettering-Integrated mutation profiling of Actionable Cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid Tumor Molecular Oncology. J Mol Diagn 17:251\u2013264","journal-title":"J Mol Diagn"},{"key":"1694_CR9","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1097\/PAS.0000000000000918","volume":"41","author":"B Xu","year":"2017","unstructured":"Xu B, Drill E, Ho A et al (2017) Predictors of Outcome in Adenoid cystic carcinoma of salivary glands: a clinicopathologic study with correlation between MYB Fusion and protein expression. Am J Surg Pathol 41:1422\u20131432","journal-title":"Am J Surg Pathol"},{"key":"1694_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/ng.3502","volume":"48","author":"Y Drier","year":"2016","unstructured":"Drier Y, Cotton MJ, Williamson KE et al (2016) An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma. Nat Genet 48:265\u2013272","journal-title":"Nat Genet"},{"key":"1694_CR11","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1038\/s41379-018-0008-8","volume":"31","author":"Y Togashi","year":"2018","unstructured":"Togashi Y, Dobashi A, Sakata S et al (2018) MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts. Mod Pathol 31:934\u2013946","journal-title":"Mod Pathol"},{"key":"1694_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.neuron.2004.08.003","volume":"43","author":"G Krapivinsky","year":"2004","unstructured":"Krapivinsky G, Medina I, Krapivinsky L, Gapon S, Clapham DE (2004) SynGAP-MUPP1-CaMKII synaptic complexes regulate p38 MAP kinase activity and NMDA receptor-dependent synaptic AMPA receptor potentiation. Neuron 43:563\u2013574","journal-title":"Neuron"},{"key":"1694_CR13","doi-asserted-by":"publisher","first-page":"D280","DOI":"10.1093\/nar\/gkac968","volume":"51","author":"Y Wang","year":"2023","unstructured":"Wang Y, Song C, Zhao J et al (2023) SEdb 2.0: a comprehensive super-enhancer database of human and mouse. Nucleic Acids Res 51:D280\u2013d90","journal-title":"Nucleic Acids Res"},{"key":"1694_CR14","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41586-020-1970-0","volume":"578","author":"C Calabrese","year":"2020","unstructured":"Calabrese C, Davidson NR, Demircio\u011flu D et al (2020) Genomic basis for RNA alterations in cancer. Nature 578:129\u2013136","journal-title":"Nature"},{"key":"1694_CR15","unstructured":"Gao Q, Liang WW, Foltz SM et al (2018) Driver fusions and their implications in the development and treatment of human cancers. Cell Rep;23:227\u2009\u2013\u200938.e3"},{"key":"1694_CR16","doi-asserted-by":"publisher","first-page":"4845","DOI":"10.1038\/onc.2014.406","volume":"34","author":"K Yoshihara","year":"2015","unstructured":"Yoshihara K, Wang Q, Torres-Garcia W et al (2015) The landscape and therapeutic relevance of cancer-associated transcript fusions. Oncogene 34:4845\u20134854","journal-title":"Oncogene"},{"key":"1694_CR17","doi-asserted-by":"crossref","unstructured":"Lind\u00e9n M, Thomsen C, Grundevik P et al (2019) FET family fusion oncoproteins target the SWI\/SNF chromatin remodeling complex. EMBO Rep;20:e45766","DOI":"10.15252\/embr.201845766"},{"key":"1694_CR18","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/PAS.0000000000002023","volume":"47","author":"I Weinreb","year":"2023","unstructured":"Weinreb I, Rooper LM, Dickson BC et al (2023) Adenoid cystic Carcinoma with striking tubular hypereosinophilia: a Unique Pattern Associated with Nonparotid Location and both canonical and novel EWSR1::MYB and FUS::MYB fusions. Am J Surg Pathol 47:497\u2013503","journal-title":"Am J Surg Pathol"},{"key":"1694_CR19","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1007\/s12105-023-01596-0","volume":"17","author":"U Yadav","year":"2023","unstructured":"Yadav U, Mahendru R, Sharma J, Kakkar A (2023) Diagnosis of Adenoid Cystic Carcinoma with striking tubular hypereosinophilia by MYB and EWSR1 breakapart fluorescence in situ hybridization. Head Neck Pathol 17:940\u2013951","journal-title":"Head Neck Pathol"},{"key":"1694_CR20","doi-asserted-by":"crossref","unstructured":"Lassche G, van Helvert S, Eijkelenboom A et al (2022) Identification of fusion genes and targets for genetically matched therapies in a large cohort of salivary gland Cancer patients. Cancers (Basel);14:4156","DOI":"10.3390\/cancers14174156"},{"key":"1694_CR21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jmoldx.2018.11.003","volume":"21","author":"CJ Troll","year":"2019","unstructured":"Troll CJ, Putnam NH, Hartley PD et al (2019) Structural variation detection by Proximity Ligation from Formalin-Fixed, paraffin-embedded Tumor tissue. J Mol Diagn 21:375\u2013383","journal-title":"J Mol Diagn"},{"key":"1694_CR22","doi-asserted-by":"publisher","first-page":"4498","DOI":"10.1158\/0008-5472.CAN-16-1944","volume":"77","author":"X Lu","year":"2017","unstructured":"Lu X, Peled N, Greer J et al (2017) MET exon 14 mutation encodes an actionable therapeutic target in Lung Adenocarcinoma. Cancer Res 77:4498\u20134505","journal-title":"Cancer Res"},{"key":"1694_CR23","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1158\/2159-8290.CD-15-0285","volume":"5","author":"GM Frampton","year":"2015","unstructured":"Frampton GM, Ali SM, Rosenzweig M et al (2015) Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors. Cancer Discov 5:850\u2013859","journal-title":"Cancer Discov"},{"key":"1694_CR24","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1056\/NEJMoa2002787","volume":"383","author":"J Wolf","year":"2020","unstructured":"Wolf J, Seto T, Han JY et al (2020) Capmatinib in MET exon 14-Mutated or MET-Amplified non-small-cell Lung Cancer. N Engl J Med 383:944\u2013957","journal-title":"N Engl J Med"},{"key":"1694_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1056\/NEJMoa2004407","volume":"383","author":"PK Paik","year":"2020","unstructured":"Paik PK, Felip E, Veillon R et al (2020) Tepotinib in Non-small-cell Lung Cancer with MET exon 14 skipping mutations. N Engl J Med 383:931\u2013943","journal-title":"N Engl J Med"},{"key":"1694_CR26","doi-asserted-by":"crossref","unstructured":"Andersson MK, Afshari MK, Andr\u00e9n Y, Wick MJ, Stenman G (2017) Targeting the oncogenic transcriptional regulator myb in adenoid cystic carcinoma by inhibition of IGF1R\/AKT signaling. J Natl Cancer Inst;109:djx017","DOI":"10.1093\/jnci\/djx017"},{"key":"1694_CR27","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1038\/nm.2580","volume":"17","author":"DR Robinson","year":"2011","unstructured":"Robinson DR, Kalyana-Sundaram S, Wu YM et al (2011) Functionally recurrent rearrangements of the MAST kinase and notch gene families in breast cancer. Nat Med 17:1646\u20131651","journal-title":"Nat Med"},{"key":"1694_CR28","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1158\/2159-8290.CD-13-0830","volume":"4","author":"A Stoeck","year":"2014","unstructured":"Stoeck A, Lejnine S, Truong A et al (2014) Discovery of biomarkers predictive of GSI response in triple-negative breast cancer and adenoid cystic carcinoma. Cancer Discov 4:1154\u20131167","journal-title":"Cancer Discov"},{"key":"1694_CR29","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.3900","volume":"49","author":"M Seki","year":"2017","unstructured":"Seki M, Kimura S, Isobe T et al (2017) Recurrent SPI1 (PU.1) fusions in high-risk pediatric T cell acute lymphoblastic leukemia. Nat Genet 49:1274\u20131281","journal-title":"Nat Genet"},{"key":"1694_CR30","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/s41467-022-29336-y","volume":"13","author":"T Liu","year":"2022","unstructured":"Liu T, Rao J, Hu W et al (2022) Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification. Nat Commun 13:1640","journal-title":"Nat Commun"},{"key":"1694_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1158\/2159-8290.CD-17-0535","volume":"8","author":"KJ Matissek","year":"2018","unstructured":"Matissek KJ, Onozato ML, Sun S et al (2018) Expressed gene fusions as frequent drivers of poor outcomes in hormone receptor-positive breast Cancer. Cancer Discov 8:336\u2013353","journal-title":"Cancer Discov"},{"key":"1694_CR32","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12105-023-01524-2","volume":"17","author":"S Patel","year":"2023","unstructured":"Patel S, Wald AI, Bastaki JM et al (2023) NKX3.1 expression and molecular characterization of secretory myoepithelial carcinoma (SMCA): advancing the case for a salivary mucous Acinar phenotype. Head Neck Pathol 17:467\u2013478","journal-title":"Head Neck Pathol"},{"key":"1694_CR33","doi-asserted-by":"publisher","first-page":"255","DOI":"10.2174\/156652411795677972","volume":"11","author":"G van Tetering","year":"2011","unstructured":"van Tetering G, Vooijs M (2011) Proteolytic cleavage of Notch: HIT and RUN. Curr Mol Med 11:255\u2013269","journal-title":"Curr Mol Med"},{"key":"1694_CR34","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1200\/JCO.2022.40.16_suppl.6046","volume":"40","author":"R Ferrarotto","year":"2022","unstructured":"Ferrarotto R, Metcalf R, Rodriguez CP et al (2022) Results of ACCURACY: a phase 2 trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent\/metastatic (R\/M) adenoid cystic carcinoma (ACC) harboring notch activating mutations (Notchmut). J Clin Oncol 40:6046","journal-title":"J Clin Oncol"},{"key":"1694_CR35","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/ng.2643","volume":"45","author":"AS Ho","year":"2013","unstructured":"Ho AS, Kannan K, Roy DM et al (2013) The mutational landscape of adenoid cystic carcinoma. Nat Genet 45:791\u2013798","journal-title":"Nat Genet"},{"key":"1694_CR36","doi-asserted-by":"publisher","first-page":"4276","DOI":"10.1172\/JCI128227","volume":"129","author":"AS Ho","year":"2019","unstructured":"Ho AS, Ochoa A, Jayakumaran G et al (2019) Genetic hallmarks of recurrent\/metastatic adenoid cystic carcinoma. J Clin Invest 129:4276\u20134289","journal-title":"J Clin Invest"},{"key":"1694_CR37","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1200\/JCO.2016.67.5264","volume":"35","author":"R Ferrarotto","year":"2017","unstructured":"Ferrarotto R, Mitani Y, Diao L et al (2017) Activating NOTCH1 mutations define a distinct subgroup of patients with adenoid cystic Carcinoma who have poor prognosis, propensity to bone and liver metastasis, and potential responsiveness to Notch1 inhibitors. J Clin Oncol 35:352\u2013360","journal-title":"J Clin Oncol"},{"key":"1694_CR38","doi-asserted-by":"publisher","first-page":"6087","DOI":"10.1200\/JCO.2022.40.16_suppl.6087","volume":"40","author":"S Rack","year":"2022","unstructured":"Rack S, Feeney L, Mistry H et al (2022) The prevalence and prognostic impact of mutations promoting chromatin remodelling dysregulation in non-resectable or recurrent\/metastatic adenoid cystic carcinoma. J Clin Oncol 40:6087","journal-title":"J Clin Oncol"}],"container-title":["Head and Neck Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01694-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12105-024-01694-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12105-024-01694-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T15:07:07Z","timestamp":1736348827000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12105-024-01694-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1694"],"URL":"https:\/\/doi.org\/10.1007\/s12105-024-01694-7","relation":{},"ISSN":["1936-0568"],"issn-type":[{"value":"1936-0568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,7]]},"assertion":[{"value":"7 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent for publication was obtained for every individual person\u2019s data included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The study is approved by the Institutional Review Board at the Memorial Sloan Kettering Cancer Center.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}],"article-number":"119"}}